BILAYER TABLET FOR PREVENTING CARDIOVASCULAR EVENTS

摘要

The present invention relates to a bilayer tablet which comprises a compa rtment containing a pharmaceutically acceptable simvastatin compound as its active ingredient; and at the same time a separate compartment containing a pharmaceutically acceptable lisinopril compound and a pharmaceutically accep table folic acid compound as active ingredients, for the prevention of strok e in high-risk conditions or diseases.